Glenmark launches Sitagliptin and its FDC at affordable price
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
This is the 142nd ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Company is investing more than €100 million in the expansion of the Halle site
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
Subscribe To Our Newsletter & Stay Updated